|
Volumn 14, Issue 4, 2000, Pages 392-394
|
Perils and pitfalls of clinical trials--experience from human oncology.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANIMAL;
ANIMAL DISEASE;
CANCER STAGING;
CLINICAL TRIAL;
DOG;
DOG DISEASE;
HUMAN;
METHODOLOGY;
NEOPLASM;
NOTE;
PHASE 2 CLINICAL TRIAL;
PRACTICE GUIDELINE;
STANDARD;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
CLINICAL TRIALS, PHASE II;
DOG DISEASES;
DOGS;
GUIDELINES;
HUMANS;
NEOPLASM STAGING;
NEOPLASMS;
RESEARCH DESIGN;
|
EID: 0034222302
PISSN: 08916640
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1939-1676.2000.tb02246.x Document Type: Note |
Times cited : (4)
|
References (0)
|